The Effect of Frailty on Balance, Activities of Daily, and Exercise Capacity in COPD
The Effect Of Frailty Level On Balance, Cognition And Activities Of Daily Living In COPD
1 other identifier
observational
48
1 country
1
Brief Summary
The investigators aim to demonstrate whether balance, cognition and activities of daily living have changed in COPD patients with and without frailty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 12, 2019
CompletedFirst Posted
Study publicly available on registry
February 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2019
CompletedDecember 1, 2023
November 1, 2023
1.6 years
February 12, 2019
November 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Presence of The Frailty Will Be evaluated Using The Frailty Criteria by Fried
Frailty will be identified by the presence of three or more of the following criteria unintentional weight loss (10 Ibs in past year), weakness (grip strength), self-reported exhaustion, slow walking speed and low physical activity. Patients with three or more of the criteria present were classified as frail.
1st Day
Balance Assessment Using Functional Reach Test
The Functional Reach Test measures how far patient can reach forward from a normal relaxed stance.
1st Day
Cognition Using MoCA-Test
Cognitive function will be evaluated with the secreening tool the Montreal Cognitive Assessment (MoCA). The MoCA is a 30-point screening tool.
1st Day
Perform activities of daily living (ADL) will be evaluated using the Glittre ADL-test
Glittre ADL-test was designed specifically to assess the functional limitation in patients with COPD. Glittre ADL-test time will be considered the main outcome variable, and will be recorded in minutes (metric).
1st Day
Secondary Outcomes (4)
Exercise Capacity Using 6-Minute Walk Test
1st Day
Disease-Related Quality of Life Assessment
1st Day
Respiratory Muscle Strength Assessment
1st Day
Shortness of Breath Assessment
1st Day
Study Arms (2)
Frail patients with COPD
No intervention
Non-frail patients with COPD
No intervention
Eligibility Criteria
Individuals who are diagnosed with COPD at Hacettepe University and who are referred to the Cardiopulmonary Rehabilitation Unit for physiotherapy also who are willing to participate in the study will be included in the study.
You may qualify if:
- COPD patients who have been clinically stable for the last four weeks and who have not undergone drug change for the last four weeks
- Being 55 years of age or older
- Accepted to participate in the study (Able and wililing to complete the informed consent process)
- Co-operate
- Patients with COPD who are ambulant without support or an assistive device
You may not qualify if:
- Neurological, cardiac or orthopedic diseases
- Other chronic diseases that may affect balance and walking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation
Ankara, Sihhiye, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deniz Inal-Ince, PhD
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
February 12, 2019
First Posted
February 15, 2019
Study Start
March 1, 2018
Primary Completion
October 15, 2019
Study Completion
October 15, 2019
Last Updated
December 1, 2023
Record last verified: 2023-11